{"entity":{"type":"insider","cik":"0001632481","url":"/insider/0001632481","json_url":"/insider/0001632481.json","name":"GEARING DAVID","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2016-03-01","last":"2016-03-07","span_basis":"filed_date"},"name_variants":[{"name":"GEARING DAVID","source":"filing","n_filings":2,"first_seen":"2016-03-01","last_seen":"2016-03-07"}],"transactions":[{"id":3342699,"accession":"0001171000-16-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001171000-16-000116","line_url":"/filing/0001171000-16-000116#line-2","is_derivative":false,"issuer_cik":"0001618561","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0001618561","owner_cik":"0001632481","owner_name":"GEARING DAVID","owner_display_name":"GEARING DAVID","owner_url":"/insider/0001632481","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":30150.0,"total_display":"30,150.00","total_whole":"30,150","shares_owned_after":125903.0,"shares_owned_after_display":"125,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-04","filed_date":"2016-03-07","scope":"insider"},{"id":3342690,"accession":"0001171000-16-000116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171000-16-000116","line_url":"/filing/0001171000-16-000116#line-1","is_derivative":false,"issuer_cik":"0001618561","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0001618561","owner_cik":"0001632481","owner_name":"GEARING DAVID","owner_display_name":"GEARING DAVID","owner_url":"/insider/0001632481","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2113.0,"shares_display":"2,113","price_per_share":3.26,"price_display":"3.26","price_state":"stated","total_value":6888.38,"total_display":"6,888.38","total_whole":"6,888","shares_owned_after":116903.0,"shares_owned_after_display":"116,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-03","filed_date":"2016-03-07","scope":"insider"},{"id":3234187,"accession":"0001572426-16-000162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001572426-16-000162","line_url":"/filing/0001572426-16-000162#line-2","is_derivative":false,"issuer_cik":"0001618561","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0001618561","owner_cik":"0001632481","owner_name":"GEARING DAVID","owner_display_name":"GEARING DAVID","owner_url":"/insider/0001632481","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12126.0,"shares_display":"12,126","price_per_share":3.34,"price_display":"3.34","price_state":"stated","total_value":40500.84,"total_display":"40,500.84","total_whole":"40,501","shares_owned_after":114790.0,"shares_owned_after_display":"114,790","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-03-01","scope":"insider"},{"id":3234180,"accession":"0001572426-16-000162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001572426-16-000162","line_url":"/filing/0001572426-16-000162#line-1","is_derivative":false,"issuer_cik":"0001618561","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0001618561","owner_cik":"0001632481","owner_name":"GEARING DAVID","owner_display_name":"GEARING DAVID","owner_url":"/insider/0001632481","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19000.0,"shares_display":"19,000","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":62700.0,"total_display":"62,700.00","total_whole":"62,700","shares_owned_after":102664.0,"shares_owned_after_display":"102,664","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-03-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001618561","name":"Nexvet Biopharma plc","url":"/issuer/0001618561","role":"Officer (CHIEF SCIENTIFIC OFFICER)","n_filings":2,"first_seen":"2016-03-01","last_seen":"2016-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001632481","retrieved_at":"2026-08-27T15:33:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}